Exscientia Plc ADR (NASDAQ:EXAI) has a beta value of 0.84 and has seen 0.45 million shares traded in the recent trading session. The company, currently valued at $612.51M, closed the recent trade at $4.85 per share which meant it lost -$0.2 on the day or -3.96% during that session. The EXAI stock price is -63.09% off its 52-week high price of $7.91 and 21.65% above the 52-week low of $3.80. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.79 million shares traded. The 3-month trading volume is 566.15K shares.
The consensus among analysts is that Exscientia Plc ADR (EXAI) is Buy stock at the moment, with a recommendation rating of 2.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.11.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exscientia Plc ADR (NASDAQ:EXAI) trade information
Sporting -3.96% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the EXAI stock price touched $4.85 or saw a rise of 14.16%. Year-to-date, Exscientia Plc ADR shares have moved -24.34%, while the 5-day performance has seen it change 13.85%. Over the past 30 days, the shares of Exscientia Plc ADR (NASDAQ:EXAI) have changed -14.76%. Short interest in the company has seen 3.64 million shares shorted with days to cover at 7.41.
Exscientia Plc ADR (EXAI) estimates and forecasts
Figures show that Exscientia Plc ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -28.36% over the past 6 months, with this year growth rate of 25.33%, compared to 16.20% for the industry. Revenue growth from the last financial year stood is estimated to be 103.30%.
3 analysts offering their estimates for the company have set an average revenue estimate of 12.85M for the current quarter. 3 have an estimated revenue figure of 23.46M for the next ending quarter. Year-ago sales stood 3.82M and 10.8M respectively for this quarter and the next, and analysts expect sales will grow by 236.40% for the current quarter and 103.30% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -116.17% over the past 5 years. Earnings growth for 2024 is a modest 35.62% while over the next 5 years, the company’s earnings are expected to increase by 16.90%.
Exscientia Plc ADR (NASDAQ:EXAI)’s Major holders
The top two institutional holders are SOFTBANK GROUP CORP. with over 5.68 million shares worth more than $32.5 million. As of 2024-03-31, SOFTBANK GROUP CORP. held 4.5748% of shares outstanding.
The other major institutional holder is LAURION CAPITAL MANAGEMENT LP, with the holding of over 5.41 million shares as of 2024-03-31. The firm’s total holdings are worth over $30.94 million and represent 4.3556% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are First Trust Nasdaq Artificial Intelligence & Robotics ETF and iShares Biotechnology ETF. As of Jul 31, 2024, the former fund manager holds about 1.33% shares in the company for having 1.61 shares of worth $7.88 million while later fund manager owns 755.77 shares of worth $3.7 million as of Jun 30, 2024, which makes it owner of about 0.63% of company’s outstanding stock.
